Get started
GENEFERM BIOTECHNOLOGY CO LTDGG

GENEFERM BIOTECHNOLOGY CO LTD

54.5TWDR
+0.5+0.93%
As of today at 01:42 GMT
TWD
No trades
See on Supercharts
Overview
Financials
Discussions Technicals Seasonals

1796 fundamentals

Key facts

Market capitalization‪2.29 B‬TWD
Dividend yield (indicated)0.00%
Price to earnings Ratio (TTM)—
Basic EPS (TTM)−0.29TWD
Founded1999
Employees (FY)—
CEOChin Te Chin
Websitegeneferm.com
About

GeneFerm Biotechnology Co., Ltd. engages in the manufacture and sale of health food and supplement. Its products include nattokinase, red yeast rice, medicinal fungi, probiotics, herbal extracts, and animal derived products such as marine collagen peptide and d-glucosamine powder. The company was founded on July 17, 1999 and is headquartered in Tainan, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪2.29 B‬‬
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
4.17x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
4.17x
Valuation ratios
‪0.00‬
‪1.10‬
‪2.20‬
‪3.30‬
‪4.40‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪20.00‬
‪40.00‬
‪60.00‬
‪80.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−10%‬
‪−5%‬
‪0%‬
‪5%‬
‪10%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−70.00 M‬‬
‪0.00‬
‪‪70.00 M‬‬
‪‪140.00 M‬‬
‪‪210.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−60.00 M‬‬
‪0.00‬
‪‪60.00 M‬‬
‪‪120.00 M‬‬
‪‪180.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪40.00 M‬‬
‪‪80.00 M‬‬
‪‪120.00 M‬‬
‪‪160.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Microbial Enzyme
Functional Products of Herbaceous Plants
Mushroom and Grasses for Food and Construction
Other
Fruit and Vegetable Enzyme Concentrate and Protein
By country
Period: 2023
Taiwan
United States
Other
China

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
‪0.00‬
‪‪250.00 M‬‬
‪‪500.00 M‬‬
‪‪750.00 M‬‬
‪‪1.00 B‬‬
Estimate
Earnings
Next:—
‪0.00‬
‪1.20‬
‪2.40‬
‪3.60‬
‪4.80‬
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
−685.40%
Payout ratio (TTM)
Dividend yield TTM
3.62%
Last payment
2.00
Last ex-date
Jul 10, 2024
Dividend history
‪0.0%‬
‪0.7%‬
‪1.4%‬
‪2.1%‬
‪2.8%‬
2019
2020
2021
2022
2023
‪0.00‬
‪0.50‬
‪1.00‬
‪1.50‬
‪2.00‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−100.00 M‬‬
‪0.00‬
‪‪100.00 M‬‬
‪‪200.00 M‬‬
‪‪300.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪200.00 M‬‬
‪‪400.00 M‬‬
‪‪600.00 M‬‬
‪‪800.00 M‬‬
Assets
Liabilities